STAT Stitch Deep Dive Podcast Beyond The Bedside

CC | Diffuse Axonal Injury (DAI)

According to your sources, Diffuse Axonal Injury (DAI) is widespread axonal damage caused by the physical forces of a mild, moderate, or severe traumatic brain injury (TBI)[1]. Physical Mechanism Traumatic Impact Forces: DAI occurs due to the tensile forces of trauma sustained during a head injury[1]. Cellular Progression: Rather than immediate shearing or tearing of the axon at the moment of impact, the trauma alters axonal functioning[1]. This leads to progressive axonal swelling and disconnection over a 12- to 24-hour period (or longer)[1]. Common Causes of Head Injuries & TBIs Because DAI is a generalized form of TBI resulting from traumatic impact, it stems from the common causes of head trauma[1][2]: Motor vehicle accidents (most common)[2] Falls (most common)[2] Sports-related trauma[2] Assaults[2] Firearms[2] Recreational injuries[2] War-related injuries

• Transcript

CC | Acute Neurological Disorders

Core Intracranial Dynamics (The 20%) Volume Distribution: The enclosed skull holds 78% brain tissue, 12% blood, and 10% CSF[1][2]. Monro-Kellie Doctrine: Intracranial volume is constant; an increase in any component requires compensatory displacement of others to maintain constant volume within the skull[2]. Key Clinical Target Values: Normal ICP is 5–15 mm Hg (sustained >20 mm Hg is abnormal)[2]. Normal CPP is 60–100 mm Hg (CPP = MAP − ICP)[3]. A CPP <50 mm Hg causes cerebral ischemia, while <30 mm Hg is incompatible with life[3]. Cerebral autoregulation maintains constant blood flow between a MAP of 70–150 mm Hg[2]. PaCO2 Impact: Elevated PaCO2 causes potent cerebral vasodilation, increasing blood volume and ICP[4]. 2. Essential Recognition & Red Flags LOC: Change in level of consciousness is the most sensitive and reliable indicator of neurological decline[5]. Cushing's Triad: Systolic hypertension with widening pulse pressure, bradycardia, and irregular respirations signify brainstem compression and impending herniation[5]. Pupils & Motor Response: A fixed, unilateral dilated pupil indicates ipsilateral CN III compression[6]. Decerebrate posturing (extensor) reflects midbrain/brainstem damage and is more severe than decorticate (flexor) posturing[6]. Compliance Loss: A ventriculostomy waveform where P2 is higher than P1 indicates compromised compliance[7][8]. 3. High-Yield Condition Comparisons Epidural Hematoma (EDH): Arterial tear (middle meningeal artery) causing rapid compression; presents with unconsciousness → lucid interval → rapid decline[9]. Requires emergency surgical evacuation[9]. Subdural Hematoma (SDH): Venous tear (bridging veins) progressing slower; chronic forms are common in older adults due to brain atrophy[9][10]. Basilar Skull Fracture: Marked by Battle's sign, raccoon eyes, and CSF otorrhea/rhinorrhea (verified via halo sign or positive glucose)[11][12]. Bacterial Meningitis: Presents with fever, severe headache, and nuchal rigidity[13]. Diagnostic LP reveals decreased CSF glucose, elevated protein, and high neutrophils[13][14]. 4. Priority Clinical Actions Airway & Position: Secure airway (GCS ≤8 requires intubation)[15]. Maintain HOB elevated 30 degrees with head midline to optimize venous drainage and CPP[16]. Avoid extreme neck or hip flexion[16]. Medical Interventions: Administer Mannitol or Hypertonic Saline to draw edema from tissue into circulation[17]. Give prompt IV antibiotics right after cultures for meningitis[14]. Critical Contraindications: Lumbar puncture is contraindicated with elevated ICP due to herniation risk[18]. Avoid NG tubes and nasotracheal suctioning in basilar fractures/CSF leaks[15][19]. Enforce respiratory isolation for meningococcal meningitis[20].

• Transcript

CC | Epidural v Subdural Hematomas

An Epidural Hematoma (EDH) and a Subdural Hematoma (SDH) are two distinct forms of focal intracranial bleeding caused by head trauma[1][2]. They differ significantly in anatomical location, primary bleeding source, clinical progression, and at-risk populations[2][3]. 1. Side-by-Side Comparison FeatureEpidural Hematoma (EDH)Subdural Hematoma (SDH)Anatomical LocationBetween the dura mater and the inner surface of the skull[2][4].Between the dura mater and the arachnoid layer of the meninges[2][4].Primary Vessel InvolvedUsually arterial (most commonly a tear of the middle meningeal artery beneath the temporal bone)[2][5]. Can occasionally be venous from a dural venous sinus tear[2].Usually venous (tear of bridging veins draining from the brain surface into the sagittal sinus)[2]. Can occasionally be arterial[2].Rate of Bleeding & OnsetRapidly developing due to high-pressure arterial expansion; considered a critical neurologic emergency[2].Usually slower to develop due to lower-pressure venous bleeding[2]. Divided into acute, subacute, and chronic forms[2][3].Classic Clinical PresentationUnconsciousness at the scene → brief lucid interval → rapid neurologic deterioration and decreased level of consciousness (LOC)[2].Symptoms of progressive increased intracranial pressure (ICP) and brain compression: headache, drowsiness, confusion, decreasing LOC, and ipsilateral fixed/dilated pupil[2].Associated Etiology & Risk FactorsFrequently associated with linear skull fractures crossing major dural arteries (e.g., temporal bone fractures)[2][5].Older adults (due to brain atrophy stretching bridging veins), alcohol use (risk of falls), and anticoagulant therapy[2][3].Surgical TreatmentRapid surgical evacuation via craniotomy or burr-hole decompression to prevent brain herniation[2][6].Surgical evacuation, decompression, or membranectomy (craniotomy or burr holes) depending on size and impairment[2]. 2. Key Clinical Nuances The EDH Lucid Interval: The hallmark of an arterial EDH is a patient who temporarily regains clarity after an initial knockout, only to rapidly deteriorate as arterial blood expands inside the closed skull[2]. Emergency surgical intervention is required before herniation occurs[2][6]. Subdural Subtypes (Acute, Subacute, Chronic): Acute SDH: Manifests within 24–48 hours of severe trauma with immediate deterioration[2]. Subacute SDH: Appears within 48 hours to 2 weeks post-injury; blood breakdown products draw fluid into the subdural space, causing late expansion[2][3]. Chronic SDH: Develops over weeks or months (often >20 days) after a seemingly minor or forgotten head injury[2][3]. Diagnostic Pitfalls in Older Adults: Chronic SDH in older adults is frequently misdiagnosed as dementia, a transient ischemic attack (TIA), or a stroke because symptoms present as subtle confusion, memory loss, and lethargy rather than acute ICP spikes[3].

• Transcript

CC | PRIMER Acute Brain Injury

Core Intracranial Dynamics (The 20%) Volume Distribution: The enclosed skull holds 78% brain tissue, 12% blood, and 10% CSF[1][2]. Monro-Kellie Doctrine: Intracranial volume is constant; an increase in any component requires compensatory displacement of others to maintain constant volume within the skull[2]. Key Clinical Target Values: Normal ICP is 5–15 mm Hg (sustained >20 mm Hg is abnormal)[2]. Normal CPP is 60–100 mm Hg (CPP = MAP − ICP)[3]. A CPP <50 mm Hg causes cerebral ischemia, while <30 mm Hg is incompatible with life[3]. Cerebral autoregulation maintains constant blood flow between a MAP of 70–150 mm Hg[2]. PaCO2 Impact: Elevated PaCO2 causes potent cerebral vasodilation, increasing blood volume and ICP[4]. 2. Essential Recognition & Red Flags LOC: Change in level of consciousness is the most sensitive and reliable indicator of neurological decline[5]. Cushing's Triad: Systolic hypertension with widening pulse pressure, bradycardia, and irregular respirations signify brainstem compression and impending herniation[5]. Pupils & Motor Response: A fixed, unilateral dilated pupil indicates ipsilateral CN III compression[6]. Decerebrate posturing (extensor) reflects midbrain/brainstem damage and is more severe than decorticate (flexor) posturing[6]. Compliance Loss: A ventriculostomy waveform where P2 is higher than P1 indicates compromised compliance[7][8]. 3. High-Yield Condition Comparisons Epidural Hematoma (EDH): Arterial tear (middle meningeal artery) causing rapid compression; presents with unconsciousness → lucid interval → rapid decline[9]. Requires emergency surgical evacuation[9]. Subdural Hematoma (SDH): Venous tear (bridging veins) progressing slower; chronic forms are common in older adults due to brain atrophy[9][10]. Basilar Skull Fracture: Marked by Battle's sign, raccoon eyes, and CSF otorrhea/rhinorrhea (verified via halo sign or positive glucose)[11][12]. Bacterial Meningitis: Presents with fever, severe headache, and nuchal rigidity[13]. Diagnostic LP reveals decreased CSF glucose, elevated protein, and high neutrophils[13][14]. 4. Priority Clinical Actions Airway & Position: Secure airway (GCS ≤8 requires intubation)[15]. Maintain HOB elevated 30 degrees with head midline to optimize venous drainage and CPP[16]. Avoid extreme neck or hip flexion[16]. Medical Interventions: Administer Mannitol or Hypertonic Saline to draw edema from tissue into circulation[17]. Give prompt IV antibiotics right after cultures for meningitis[14]. Critical Contraindications: Lumbar puncture is contraindicated with elevated ICP due to herniation risk[18]. Avoid NG tubes and nasotracheal suctioning in basilar fractures/CSF leaks[15][19]. Enforce respiratory isolation for meningococcal meningitis[20].

• Transcript

CC | Stroke [CVA] Additional Information

this episode goes over the 4 kinds of stokes from a high level overview

• Transcript

CC CJM | Intro

the intro episode to the clinical judgement model

• Transcript

CC CJM | Burns

Burn Classification & TBSA Assessment Burn severity depends on depth, extent (TBSA), location, and patient risk factors[1]. Depth is classified as partial-thickness (epidermal/dermal; painful, red, blistered) or full-thickness (dermal destruction, painless, leathery eschar, visible thrombosed vessels)[2]. TBSA is estimated using the Rule of Nines for adults or the Lund-Browder chart for children[6]. Referral to a burn center is indicated for partial-thickness burns >10% TBSA, chemical/electrical burns, inhalation injury, or burns of the face, hands, feet, genitalia, perineum, or joints[7]. Face, neck, and circumferential torso burns threaten ventilation[8]. Circumferential limb burns impair perfusion, requiring escharotomy[8][9]. Emergent Phase Pathophysiology & Resuscitation The emergent phase (first 72 hours) prioritizes burn shock and gas exchange[10]. Loss of capillary seal triggers a massive fluid shift from the intravascular to the interstitial space (third spacing), causing severe hypovolemia, hemoconcentration, high blood viscosity, and increased peripheral resistance[10]. Damaged cells release potassium (hyperkalemia), and sodium moves into the interstitium (hyponatremia)[13][14]. Inhalation injuries (carbon monoxide, above/below glottis) cause mucosal edema, obstruction, and pneumonia (the leading cause of death)[9]. Myoglobinuria (from electrical muscle damage) can block renal tubules, causing acute kidney injury (AKI)[18][19]. Priority care includes early intubation, 100% humidified O2, and resuscitation[20][21]. The ABA formula dictates 2–4 mL Lactated Ringer's per kg per % TBSA in the first 24 hours (half in the first 8 hours)[22]. Target clinical parameters are MAP >65 mmHg, HR <120 bpm, and adult urine output of 0.5–1 mL/kg/hr (75–100 mL/hr for electrical burns)[25]. Acute, Rehabilitative & Psychosocial Care The acute phase begins with diuresis and ends when wounds are nearly healed[26]. Sepsis, often from gram-negative bacteria or Candida, is a leading cause of death during this immunosuppressed period[27][28]. Stress-induced hypermetabolism causes protein catabolism and transient hyperglycemia, requiring early enteral nutrition and insulin[29]. Excision and grafting (autograft, CEA, or Integra) are vital for full-thickness wounds[32]. Pain is managed with continuous IV opioids, procedural breakthrough doses, and anxiolytics[36][37]. Continuous physical therapy and splinting prevent contractures[38][39]. In the rehabilitation phase, hypertrophic scars are minimized using custom-fitted pressure garments worn up to 23 hours daily for 12–18 months[40][41]. Hydration and antihistamines help relieve severe itching[40][42]. Older adults face higher mortality due to thinner skin, delayed healing, and co-morbidities[43]. Support groups and psychiatric interventions address emotional needs, body image changes, and PTSD[44].

• Transcript

CC CJM | Chronic Neurological Disorders

Primary Headaches[1] Tension (TTH): Bilateral, dull bandlike pressure[1][2]. No nausea[2]. Tx: NSAIDs[3][4]. Prev: Amitriptyline[3][5]. Migraine: Unilateral throbbing, ± aura[1][6]. Triggers: stress, red wine[6][7]. Acute: Triptans (sumatriptan; contraindicated in CAD, ischemic stroke, uncontrolled HTN)[5]. Prev: Topiramate, β-blockers, Botox[3]. Cluster: Severe unilateral orbital pain in clusters[1][4]. ptosis, tearing[1][4]. Tx: High-flow 100% O2 (7-12 L/min)[3][8], triptans[8]. Prev: Verapamil[8]. Medication Overuse (MOH): Daily headache from analgesic overuse. Tx: Stop drug[8]. Seizure Disorders[9] Def: ≥2 unprovoked seizures >24h apart[9]. Classes: Generalized (bilateral hemispheres, e.g., tonic-clonic with LOC[10][11]) vs. Focal (1 hemisphere, aware vs. impaired[10][12]). Status Epilepticus (SE): Seizure >5 min or recurrent; emergency[12]. Tx: IV Lorazepam, then fosphenytoin[13]. Nursing Care: Airway, turn on side, do not restrain, never insert objects in mouth, pad rails, record phases[14][15]. Restless Legs Syndrome (RLS)[16] Leg paresthesias, worse at rest/night, relieved by movement[16][17]. Basal ganglia dopamine dysfunction[17]. Tx: Dopamine agonists (ropinirole), gabapentin[17]. Degenerative Neurologic Disorders[1] Multiple Sclerosis (MS): Autoimmune T-cell CNS demyelination[18][19]. Signs: optic neuritis, spasticity, ataxia, bladder dysfunction[20][21]. Tx: DMDs (interferons)[22], steroids for relapses[22]. Parkinson's (PD): Substantia nigra DA neuron loss; DA/ACh imbalance[23]. Key: resting tremor ("pill-rolling"), cogwheel rigidity, bradykinesia (masked facies, shuffling gait), postural instability[23]. Tx: Levodopa/Carbidopa (avoid protein meals[26]), DA agonists, DBS[25]. Myasthenia Gravis (MG): Autoimmune AChR antibody destruction[29]. Fluctuating weakness (ptosis/diplopia; worsens with activity, improves with rest)[29]. Dx: Edrophonium test (atropine bedside)[30]. Myasthenic Crisis: Respiratory failure[30]; Tx: IVIG, plasmapheresis[31]. Cholinergic Crisis: Excess anticholinestase[30]; SLUDGE signs[30]; Tx: hold drugs, atropine[30]. Tx: Pyridostigmine[30]. Amyotrophic Lateral Sclerosis (ALS): Upper/lower motor neuron degeneration; cognition spared[32][33]. Wasting, bulbar signs. Death: respiratory failure[32]. Tx: Riluzole[32]. Huntington's (HD): Autosomal dominant CAG repeats[33]. ACh/GABA deficit, excess DA[33]. Key: chorea, psychiatric decline, dementia[33][34]. Caloric needs: 4000-5000 kcal/day[34]. Tx: Tetrabenazine[34].

• Transcript

CC CJM | Stroke [CVA]

80/20 Clinical Stroke Summary Core Concepts & Emergency Recognition A stroke is an emergency where cell death occurs due to ischemia (inadequate blood flow, 87% of cases) or hemorrhage (bleeding, 13%)[1][2]. Interruption of blood flow alters brain metabolism in 30 seconds, stops it in 2 minutes, and causes cell death in 5 minutes[3]. The FAST protocol is critical for rapid recognition: Face drooping, Arm weakness/drift, Speech difficulties, and Time of symptom onset (critical for determining treatment eligibility)[1]. Pathophysiology & Classification Ischemic Stroke: Divided into Thrombotic (60% of cases; associated with hypertension, diabetes, and atherosclerosis; symptoms develop slowly/stepwise)[2][6] and Embolic (clot from the heart, often due to atrial fibrillation, travels and occludes a cerebral artery; onset is sudden with severe deficits)[2]. Hemorrhagic Stroke: Includes Intracerebral (bleeding into brain tissue, mostly caused by hypertension)[2]and Subarachnoid (SAH) (bleeding into CSF-filled space, often from ruptured aneurysms)[9]. SAH can trigger severe vasospasms, peaking 6–10 days post-bleed[10]. Key Diagnostics & Triage Immediate noncontrast head CT or MRI is mandatory to rapidly differentiate ischemic from hemorrhage[4]. The NIH Stroke Scale (NIHSS) (scores 0–42) is the primary clinical tool to document baseline severity and track neurologic changes[11][12]. Acute Interventions & Hemodynamic Targets Ischemic: IV tPA must be given within 3 to 4.5 hours of symptom onset after screening out hemorrhage, active bleeding, or recent trauma[13]. Endovascular therapy with stent retrievers is highly effective[14]. Keep BP <185/110 mmHg before tPA, and <180/105 mmHg for 24 hours after[5]. If ineligible for tPA, lower BP only if SBP >220 or DBP >120 mmHg[5]. Hemorrhagic: Anticoagulants and antiplatelets are strictly contraindicated[14]. Manage hypertension to maintain SBP <160 mmHg[14]. For SAH, administer the calcium channel blocker nimodipine to prevent vasospasm[11][15]. High-Priority Nursing ADPIE Actions Airway & Aspiration: Keep the patient NPO until a formal swallowing screen is completed within 24 hours to prevent aspiration pneumonia[5]. ICP Management: Elevate the head of bed 30°, keep head/neck in midline, and avoid hip flexion to maximize venous drainage and reduce intracranial pressure[13][16]. Safety & Pattern Recognition: Left-brain stroke causes right hemiplegia, aphasia, slow/cautious behavior, and depression[18]. Right-brain stroke causes left hemiplegia, spatial-perceptual neglect, and highly impulsive, safety-compromising behavior[18][19]. Protect from injury and address one-sided neglect[19][20]. VTE Prophylaxis: Implement passive/active range of motion, sequential compression devices, and low-molecular-weight heparin[21].

• Transcript

CC CJM | CKD v AKI

80/20 Clinical Summary: Renal Failure (AKI vs. CKD) 1. Pathophysiology AKI: Sudden, potentially reversible decline in GFR[1]. Prerenal: Decreased perfusion (hypovolemia, shock, HF). Oliguria occurs without tissue damage; reversible with fluids[1][2]. Intrarenal: Direct tissue damage, 90% from Acute Tubular Necrosis (ATN) (ischemia, sepsis, nephrotoxins)[2]. Postrenal: Mechanical obstruction (BPH, calculi) causing urine reflux[3]. CKD: Gradual, irreversible nephron loss (GFR <60 for >3 months)[4]. Primary causes: Diabetes (50%), Hypertension (25%)[4]. Stage 5 (ESRD) GFR <15[5]. 2. Clinical Phases & Manifestations AKI Phases: Oliguric (<400 mL/d): Fluid overload (edema, hypertension, pulmonary edema), acidosis, hyperkalemia (ECG: peaked T, wide QRS), and uremia[3][6]. Diuretic (1–5+ L/d): Osmotic diuresis (high urea). Risk of hypovolemia, hypotension, hyponatremia, and hypokalemia[7]. Recovery: GFR increases, BUN/Creatinine stabilize (takes up to 12 months)[7]. CKD Manifestations (Uremia): Cardiovascular: Leading cause of death; due to vascular calcification, volume overload, and hypertension[8][9]. Hematologic: Anemia from decreased erythropoietin[10]. CKD-MBD: Low active Vitamin D reduces calcium absorption[11]. Hypocalcemia triggers PTH release, causing bone demineralization (osteomalacia, osteitis fibrosa) and calcifications[12]. 3. Diagnostics & Priority Interventions Metrics: GFR is the best indicator of kidney function[8][13]. Creatinine is the best AKI marker[6]. Proteinuria is first sign of CKD[13]. Hyperkalemia Emergency Care: Cardioprotection: IV Calcium Gluconate (stabilizes myocardium)[14]. Shift K+ Intracellularly: IV Regular Insulin + Glucose, or IV Sodium Bicarbonate[14]. Definitive Removal: Hemodialysis or Kayexalate (avoid in paralytic ileus due to bowel necrosis)[14][15]. Fluid Limits: Oliguric AKI: previous 24-hr loss + 600 mL[14]. Anemia: Exogenous EPO. Monitor for hypertension, clots; supplement iron[16]. 4. RRT & Post-Op Care HD: Rapid fluid/solute shifts. Assess AV Fistula for thrill and bruit[17]. Safety: No BP/blood draws/IVs in access arm[18]. Complication: Hypotension, cramps[19]. PD: Uses peritoneal membrane. Core complication: Peritonitis (abdominal pain, rebound tenderness, cloudy effluent)[20][21]. CRRT: Slow, continuous solute/fluid removal for hemodynamically unstable AKI[22][23]. Transplantation: Post-op priority is fluid/electrolyte balance[24]. Watch for massive diuresis (replace mL-for-mL) or ATN[24]. CVD is the leading cause of death post-transplant[25].

• Transcript

CC CJM | Neuro Assessment

80/20 Neurological Assessment & Physiology Summary 1. Structure & Cellular Biology Organization: The CNS consists of the brain, spinal cord, and CN I-II[1]. The PNS contains CN III-XII, spinal nerves, and the ANS[1]. Cells & Myelin: Neurons conduct action potentials via saltatory conduction across nodes of Ranvier, accelerated by myelin[2]. Astrocytes form the blood-brain barrier and create scar tissue (gliosis) upon injury[2]. Oligodendrocytes myelinate CNS axons; Schwann cells myelinate PNS axons[2][3]. Synapses: Neurotransmitters cross synapses to alter impulse transmission, using excitatory (glutamate) or inhibitory (GABA) pathways[4]. 2. Pathways, Lobes & Perfusion Tracts: Ascending tracts carry sensory input (spinothalamic for pain/temp; dorsal columns for touch, vibration, position)[5]. Descending tracts (corticospinal) carry motor output[5]. Motor Lesions: UMN lesions cause spasticity, hyperreflexia, and weakness[6]. LMN lesions cause flaccidity, hyporeflexia, and muscle atrophy[6]. Cerebral Lobes: Frontal lobe controls cognition and motor speech (Broca's)[7]. Parietal lobe senses sensory data[7]. Temporal lobe handles hearing/language (Wernicke's); occipital processes vision[7]. Perfusion: Anterior circulation stems from carotids; posterior from vertebral-basilar systems, joining at the circle of Willis[8]. 3. Bedside Assessment Mental Status: Ongoing check of consciousness, orientation, cognition, and mood/affect[9]. Cranial Nerves: CN III, IV, VI coordinate eye movements[10]. Pupil non-constriction (CN III) is an early sign of brain herniation[10]. Corneal reflex tests CN V/VII[11]. Gag reflex tests CN IX/X; a weak gag risks aspiration[12]. Midline tongue protrusion checks CN XII[12]. Sensory & Proprioception: Test touch, pain, vibration, and digit position[13][14]. A positive Romberg test indicates posterior column dysfunction[15]. Reflexes: Deep tendon reflexes are graded 0–5[15]. An extensor plantar response (toes up) signals an abnormal UMN lesion[16]. 4. Diagnostics & Nursing Interventions CSF Analysis: Normal CSF is clear/colorless, with pressure of 60–150 mm H2O, protein of 15–45 mg/dL, and glucose of 40–70 mg/dL[16]. Lumbar Puncture (LP) Care: LP is contraindicated in increased ICP due to risk of herniation[17]. Pre-procedure, check coagulation and place the patient in a sitting/side-lying flexed position[18][19]. Post-procedure, keep flat, monitor for headache, and push fluids[18]. Aging: Aging causes cerebral atrophy, wider ventricles, reduced blood flow, and demyelination[20]. This leads to orthostatic hypotension, poor thermoregulation, and high fall risks[20][21].

• Transcript

CC CJM | Blood Disorders

Clinician’s 80/20 Hematologic & Anemia Summary Core Clinical Concepts Blood disorders disrupt homeostasis. Key pathological threads include: Fatigue: Secondary to tissue hypoxia (anemia, cancer). Infection Risk: Compromised immunity and risk for infection is a major concern in hematologic cancers and a common side effect of therapy. Pain: Common and classic in sickle cell disease (SCD) and oncology. Perfusion & Clotting: Excessive clotting impairs perfusion; inadequate clotting causes blood loss and fluid volume deficit[1]. Anemia: Definition & Pathophysiology Anemia is not a disease but a manifestation of an underlying pathologic process[2]. It is defined as a deficit in red blood cell (RBC) count, hemoglobin (Hgb) quantity/quality, and/or volume of packed red blood cells (hematocrit)[2]. Tissue hypoxia drives all clinical findings[3]. The body compensates via cardiopulmonary escalation, increasing heart rate (HR) and stroke volume to maintain cardiac output (CO)[4]. Low blood viscosity contributes to systolic murmurs and bruits[4]. If O2 demand exceeds supply, angina or MI occurs[4]. Chronic overwork leads to heart failure (HF), cardiomegaly, congestion, and peripheral edema[4]. Diagnostics & Classification Diagnostics rely on CBC, reticulocyte count, and peripheral smear[2]. Anemia is classified by: Morphology (RBC size/color): Most accurate framework[5]. Normocytic, Normochromic (MCV 80–95 fL, MCH 27–31 pg): Caused by acute blood loss, hemolysis, CKD, cancers, or SCD[6]. Microcytic, Hypochromic (MCV <80 fL, MCH <27 pg): Caused by iron deficiency, thalassemia, lead poisoning, B6/copper deficiency[6]. Macrocytic, Normochromic (MCV >95 fL, MCH >31 pg): Caused by B12 (cobalamin) deficiency, folic acid deficiency, or liver disease[6]. Etiology (Cause): Best for structuring care[5]. Divided into decreased RBC production, blood loss, or increased RBC destruction (hereditary like SCD/G6PD vs. acquired like DIC, HELLP, prosthetic valves, or bypass)[7]. Severity & Clinical Manifestations Symptoms depend on onset speed, severity, and Hgb level[3]: Mild (Hgb 10–12 g/dL): Often asymptomatic. Heavy exercise triggers compensatory palpitations, mild fatigue, and dyspnea[3]. Moderate (Hgb 6–10 g/dL): Cardiopulmonary symptoms (dyspnea, palpitations) occur both during activity and at rest[11]. Severe (Hgb <6 g/dL): Multi-system decompensation occurs[11]. Integumentary: Pallor (shunted blood flow), jaundice (bilirubin from RBC hemolysis), and severe itching (accumulation of skin bile)[11]. Cardiopulmonary: Marked tachycardia, angina, murmurs, and congestive failure[4].

• Transcript

CC CJM | DKA v HHS

. DM Classification & Core Diagnostics Type 1 DM: Autoimmune β-cell destruction (HLA-DR3/DR4) causing absolute insulin deficiency; presents abruptly with classic 3 Ps (polyuria, polydipsia, polyphagia), weight loss, and DKA risk[1][2]. Type 2 DM: Insulin resistance combined with relative β-cell deficiency and inappropriate hepatic glucose production[3]. Onset is gradual[4]. Diagnostic Criteria: A1C ≥6.5%, Fasting Plasma Glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, or Random Glucose ≥200 mg/dL with classic symptoms[5]. Glycemic target A1C is <7.0%[6]. 2. High-Yield Pharmacotherapy & Insulin Dynamics Insulin Types: Rapid-acting (lispro, aspart; onset 10–30 min, mealtime bolus), Short-acting (Regular; onset 30–60 min, only IV insulin), Intermediate (NPH; peaks 4–12 hr, cloudy), Long-acting (glargine, detemir; peakless basal)[7]. Basal-Bolus Strategy: Optimal plan mimicking normal endogenous insulin secretion[7]. Key Oral Agents: Metformin (Biguanide) reduces hepatic glucose output[10]. Safety Alert: Discontinue metformin 48 hr before/after IV contrast to prevent acute kidney injury and lactic acidosis[10][11]. Sulfonylureas (glipizide) stimulate insulin release and carry high hypoglycemia risk[11][12]. 3. Hyperglycemic Emergencies: DKA vs. HHS DKA (T1DM): Absolute insulin deficiency → uncontrolled lipolysis → ketone bodies → metabolic acidosis (pH <7.30, HCO₃⁻ <16 mEq/L), Kussmaul respirations, fruity breath, glucose >250 mg/dL[13][14]. HHS (T2DM): Enough circulating insulin prevents ketosis, but severe hyperglycemia (>600 mg/dL) causes osmotic diuresis, hyperosmolality, and profound neurologic deficits (coma, seizures)[15][16]. Emergency Treatment Protocol: IV Fluids: First priority. 0.9% NaCl (1 L/hr) to maintain urine output (30–60 mL/hr)[14][15]. Add 5%–10% dextrose when glucose reaches ~250 mg/dL to prevent hypoglycemia and cerebral edema[14][15]. Potassium: Check K⁺ BEFORE starting insulin. Insulin shifts K⁺ intracellularly, causing life-threatening hypokalemia if uncorrected[15]. Continuous IV Regular Insulin: 0.1 U/kg/hr; target glucose reduction of 36–54 mg/dL/hr[15]. 4. Hypoglycemia & Chronic Complications Hypoglycemia (<70 mg/dL): Treat via Rule of 15 (15–20g fast-acting carbs, recheck in 15 min)[16][17]. Unconscious: 20–50 mL 50% Dextrose IV or 1 mg Glucagon IM/SQ (turn on side to prevent aspiration)[17]. Chronic Complications: Driven by angiopathy[18]. Macrovascular (CVD, stroke, PAD) managed via BP (<140/90) and lipid control[19]. Microvascular annual screening: Retinopathy (dilated eye exam), Nephropathy (urine albumin/creatinine; treat with ACEi/ARBs), and Neuropathy (monofilament test, daily foot inspection)[20].

• Transcript

CC CJM | GU

Urinary System: 80/20 Summary 1. Anatomy & Blood Supply The upper urinary tract has two retroperitoneal, bean-shaped kidneys (T12–L3) and 2 ureters[1]. The lower tract comprises the bladder and urethra[1]. Each kidney is shielded by a fibrous capsule and cushioned by fat[1]. The functional unit is the nephron (~1 million), consisting of a glomerulus, Bowman's capsule, and tubule system (PCT, loop of Henle, DCT, and collecting ducts)[2]. Blood flow is ~1200 mL/min (20-25% of cardiac output) via the renal artery, which divides into afferent arterioles[2]. 2. Physiology of Urine Formation Urine is formed through filtration, reabsorption, secretion, and excretion[2]. Glomerular Filtration: Hydrostatic pressure filters blood across a porous, semipermeable membrane into Bowman’s capsule, yielding a filtrate lacking cells and large proteins[3]. Normal Glomerular Filtration Rate (GFR) is ~125 mL/min; only ~1 mL/min is excreted as urine[3]. Tubular Function: PCT: Reabsorbs 80% of electrolytes and water, all glucose, amino acids, and bicarbonate; secretes H+ and creatinine[4]. Loop of Henle: Conserves water and concentrates filtrate. Descending loop is water-permeable; ascending limb actively reabsorbs Cl- and Na+ (25% of sodium load) and is water-impermeable[4]. DCT & Collecting Ducts: Finalize regulation of water (controlled by ADH, which increases permeability) and acid-base balance (reabsorbing HCO3- and secreting H+)[4][5]. Aldosterone promotes Na+ and water reabsorption in exchange for K+ excretion[5]. Atrial Natriuretic Peptide (ANP) opposes this by increasing Na+ excretion and GFR[5]. 3. Hormonal & Regulatory Functions Erythropoietin: Released during hypoxia or hypoperfusion, stimulating RBC production (deficient in renal failure, causing anemia)[5]. RAAS: Juxtaglomerular cells release renin during hypoperfusion, low BP, or hyponatremia. Renin converts angiotensinogen to angiotensin I, which ACE converts to angiotensin II—causing vasoconstriction and aldosterone release[6]. Prostaglandins (PGE2, PGI2): Medullary vasodilators that maintain renal blood flow and counteract vasoconstrictors[7]. Vitamin D: Kidneys perform the final activation step of vitamin D, essential for calcium absorption[5]. 4. Diagnostics & Assessment Key Labs: Serum creatinine is the most reliable renal function index (released at a constant rate from muscle)[8][9]. Creatinine clearance (24-hr urine) approximates GFR[9][10]. BUN rises with dysfunction but is altered by protein intake, tissue breakdown, and hydration[8]. Physical Exam: Involves palpation of the right kidney and indirect fist percussion of the costovertebral angle (CVA) to elicit pain in infection or obstruction[11][12]. Nephrotoxic Risks: Drugs like aminoglycosides, NSAIDs, and contrast media are highly nephrotoxic[13]. Dehydration increases the risk of contrast-induced nephropathy[9].

• Transcript

CC | DKA & HHS

1. DM Classification & Core Diagnostics Type 1 DM: Autoimmune β-cell destruction (HLA-DR3/DR4) causing absolute insulin deficiency; presents abruptly with classic 3 Ps (polyuria, polydipsia, polyphagia), weight loss, and DKA risk[1][2]. Type 2 DM: Insulin resistance combined with relative β-cell deficiency and inappropriate hepatic glucose production[3]. Onset is gradual[4]. Diagnostic Criteria: A1C ≥6.5%, Fasting Plasma Glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, or Random Glucose ≥200 mg/dL with classic symptoms[5]. Glycemic target A1C is <7.0%[6]. 2. High-Yield Pharmacotherapy & Insulin Dynamics Insulin Types: Rapid-acting (lispro, aspart; onset 10–30 min, mealtime bolus), Short-acting (Regular; onset 30–60 min, only IV insulin), Intermediate (NPH; peaks 4–12 hr, cloudy), Long-acting (glargine, detemir; peakless basal)[7]. Basal-Bolus Strategy: Optimal plan mimicking normal endogenous insulin secretion[7]. Key Oral Agents: Metformin (Biguanide) reduces hepatic glucose output[10]. Safety Alert: Discontinue metformin 48 hr before/after IV contrast to prevent acute kidney injury and lactic acidosis[10][11]. Sulfonylureas (glipizide) stimulate insulin release and carry high hypoglycemia risk[11][12]. 3. Hyperglycemic Emergencies: DKA vs. HHS DKA (T1DM): Absolute insulin deficiency → uncontrolled lipolysis → ketone bodies → metabolic acidosis (pH <7.30, HCO₃⁻ <16 mEq/L), Kussmaul respirations, fruity breath, glucose >250 mg/dL[13][14]. HHS (T2DM): Enough circulating insulin prevents ketosis, but severe hyperglycemia (>600 mg/dL) causes osmotic diuresis, hyperosmolality, and profound neurologic deficits (coma, seizures)[15][16]. Emergency Treatment Protocol: IV Fluids: First priority. 0.9% NaCl (1 L/hr) to maintain urine output (30–60 mL/hr)[14][15]. Add 5%–10% dextrose when glucose reaches ~250 mg/dL to prevent hypoglycemia and cerebral edema[14][15]. Potassium: Check K⁺ BEFORE starting insulin. Insulin shifts K⁺ intracellularly, causing life-threatening hypokalemia if uncorrected[15]. Continuous IV Regular Insulin: 0.1 U/kg/hr; target glucose reduction of 36–54 mg/dL/hr[15]. 4. Hypoglycemia & Chronic Complications Hypoglycemia (<70 mg/dL): Treat via Rule of 15 (15–20g fast-acting carbs, recheck in 15 min)[16][17]. Unconscious: 20–50 mL 50% Dextrose IV or 1 mg Glucagon IM/SQ (turn on side to prevent aspiration)[17]. Chronic Complications: Driven by angiopathy[18]. Macrovascular (CVD, stroke, PAD) managed via BP (<140/90) and lipid control[19]. Microvascular annual screening: Retinopathy (dilated eye exam), Nephropathy (urine albumin/creatinine; treat with ACEi/ARBs), and Neuropathy (monofilament test, daily foot inspection)[20].

• Transcript

VS CC | DKA V HHS

1. DM Classification & Core Diagnostics Type 1 DM: Autoimmune β-cell destruction (HLA-DR3/DR4) causing absolute insulin deficiency; presents abruptly with classic 3 Ps (polyuria, polydipsia, polyphagia), weight loss, and DKA risk[1][2]. Type 2 DM: Insulin resistance combined with relative β-cell deficiency and inappropriate hepatic glucose production[3]. Onset is gradual[4]. Diagnostic Criteria: A1C ≥6.5%, Fasting Plasma Glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, or Random Glucose ≥200 mg/dL with classic symptoms[5]. Glycemic target A1C is <7.0%[6]. 2. High-Yield Pharmacotherapy & Insulin Dynamics Insulin Types: Rapid-acting (lispro, aspart; onset 10–30 min, mealtime bolus), Short-acting (Regular; onset 30–60 min, only IV insulin), Intermediate (NPH; peaks 4–12 hr, cloudy), Long-acting (glargine, detemir; peakless basal)[7]. Basal-Bolus Strategy: Optimal plan mimicking normal endogenous insulin secretion[7]. Key Oral Agents: Metformin (Biguanide) reduces hepatic glucose output[10]. Safety Alert: Discontinue metformin 48 hr before/after IV contrast to prevent acute kidney injury and lactic acidosis[10][11]. Sulfonylureas (glipizide) stimulate insulin release and carry high hypoglycemia risk[11][12]. 3. Hyperglycemic Emergencies: DKA vs. HHS DKA (T1DM): Absolute insulin deficiency → uncontrolled lipolysis → ketone bodies → metabolic acidosis (pH <7.30, HCO₃⁻ <16 mEq/L), Kussmaul respirations, fruity breath, glucose >250 mg/dL[13][14]. HHS (T2DM): Enough circulating insulin prevents ketosis, but severe hyperglycemia (>600 mg/dL) causes osmotic diuresis, hyperosmolality, and profound neurologic deficits (coma, seizures)[15][16]. Emergency Treatment Protocol: IV Fluids: First priority. 0.9% NaCl (1 L/hr) to maintain urine output (30–60 mL/hr)[14][15]. Add 5%–10% dextrose when glucose reaches ~250 mg/dL to prevent hypoglycemia and cerebral edema[14][15]. Potassium: Check K⁺ BEFORE starting insulin. Insulin shifts K⁺ intracellularly, causing life-threatening hypokalemia if uncorrected[15]. Continuous IV Regular Insulin: 0.1 U/kg/hr; target glucose reduction of 36–54 mg/dL/hr[15]. 4. Hypoglycemia & Chronic Complications Hypoglycemia (<70 mg/dL): Treat via Rule of 15 (15–20g fast-acting carbs, recheck in 15 min)[16][17]. Unconscious: 20–50 mL 50% Dextrose IV or 1 mg Glucagon IM/SQ (turn on side to prevent aspiration)[17]. Chronic Complications: Driven by angiopathy[18]. Macrovascular (CVD, stroke, PAD) managed via BP (<140/90) and lipid control[19]. Microvascular annual screening: Retinopathy (dilated eye exam), Nephropathy (urine albumin/creatinine; treat with ACEi/ARBs), and Neuropathy (monofilament test, daily foot inspection)[20].

• Transcript

CC V | DKA V HHS

1. DM Classification & Core Diagnostics Type 1 DM: Autoimmune β-cell destruction (HLA-DR3/DR4) causing absolute insulin deficiency; presents abruptly with classic 3 Ps (polyuria, polydipsia, polyphagia), weight loss, and DKA risk[1][2]. Type 2 DM: Insulin resistance combined with relative β-cell deficiency and inappropriate hepatic glucose production[3]. Onset is gradual[4]. Diagnostic Criteria: A1C ≥6.5%, Fasting Plasma Glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, or Random Glucose ≥200 mg/dL with classic symptoms[5]. Glycemic target A1C is <7.0%[6]. 2. High-Yield Pharmacotherapy & Insulin Dynamics Insulin Types: Rapid-acting (lispro, aspart; onset 10–30 min, mealtime bolus), Short-acting (Regular; onset 30–60 min, only IV insulin), Intermediate (NPH; peaks 4–12 hr, cloudy), Long-acting (glargine, detemir; peakless basal)[7]. Basal-Bolus Strategy: Optimal plan mimicking normal endogenous insulin secretion[7]. Key Oral Agents: Metformin (Biguanide) reduces hepatic glucose output[10]. Safety Alert: Discontinue metformin 48 hr before/after IV contrast to prevent acute kidney injury and lactic acidosis[10][11]. Sulfonylureas (glipizide) stimulate insulin release and carry high hypoglycemia risk[11][12]. 3. Hyperglycemic Emergencies: DKA vs. HHS DKA (T1DM): Absolute insulin deficiency → uncontrolled lipolysis → ketone bodies → metabolic acidosis (pH <7.30, HCO₃⁻ <16 mEq/L), Kussmaul respirations, fruity breath, glucose >250 mg/dL[13][14]. HHS (T2DM): Enough circulating insulin prevents ketosis, but severe hyperglycemia (>600 mg/dL) causes osmotic diuresis, hyperosmolality, and profound neurologic deficits (coma, seizures)[15][16]. Emergency Treatment Protocol: IV Fluids: First priority. 0.9% NaCl (1 L/hr) to maintain urine output (30–60 mL/hr)[14][15]. Add 5%–10% dextrose when glucose reaches ~250 mg/dL to prevent hypoglycemia and cerebral edema[14][15]. Potassium: Check K⁺ BEFORE starting insulin. Insulin shifts K⁺ intracellularly, causing life-threatening hypokalemia if uncorrected[15]. Continuous IV Regular Insulin: 0.1 U/kg/hr; target glucose reduction of 36–54 mg/dL/hr[15]. 4. Hypoglycemia & Chronic Complications Hypoglycemia (<70 mg/dL): Treat via Rule of 15 (15–20g fast-acting carbs, recheck in 15 min)[16][17]. Unconscious: 20–50 mL 50% Dextrose IV or 1 mg Glucagon IM/SQ (turn on side to prevent aspiration)[17]. Chronic Complications: Driven by angiopathy[18]. Macrovascular (CVD, stroke, PAD) managed via BP (<140/90) and lipid control[19]. Microvascular annual screening: Retinopathy (dilated eye exam), Nephropathy (urine albumin/creatinine; treat with ACEi/ARBs), and Neuropathy (monofilament test, daily foot inspection)[20].

CC | DKA & HHS

1. DM Classification & Core Diagnostics Type 1 DM: Autoimmune β-cell destruction (HLA-DR3/DR4) causing absolute insulin deficiency; presents abruptly with classic 3 Ps (polyuria, polydipsia, polyphagia), weight loss, and DKA risk[1][2]. Type 2 DM: Insulin resistance combined with relative β-cell deficiency and inappropriate hepatic glucose production[3]. Onset is gradual[4]. Diagnostic Criteria: A1C ≥6.5%, Fasting Plasma Glucose ≥126 mg/dL, 2-hr OGTT ≥200 mg/dL, or Random Glucose ≥200 mg/dL with classic symptoms[5]. Glycemic target A1C is <7.0%[6]. 2. High-Yield Pharmacotherapy & Insulin Dynamics Insulin Types: Rapid-acting (lispro, aspart; onset 10–30 min, mealtime bolus), Short-acting (Regular; onset 30–60 min, only IV insulin), Intermediate (NPH; peaks 4–12 hr, cloudy), Long-acting (glargine, detemir; peakless basal)[7]. Basal-Bolus Strategy: Optimal plan mimicking normal endogenous insulin secretion[7]. Key Oral Agents: Metformin (Biguanide) reduces hepatic glucose output[10]. Safety Alert: Discontinue metformin 48 hr before/after IV contrast to prevent acute kidney injury and lactic acidosis[10][11]. Sulfonylureas (glipizide) stimulate insulin release and carry high hypoglycemia risk[11][12]. 3. Hyperglycemic Emergencies: DKA vs. HHS DKA (T1DM): Absolute insulin deficiency → uncontrolled lipolysis → ketone bodies → metabolic acidosis (pH <7.30, HCO₃⁻ <16 mEq/L), Kussmaul respirations, fruity breath, glucose >250 mg/dL[13][14]. HHS (T2DM): Enough circulating insulin prevents ketosis, but severe hyperglycemia (>600 mg/dL) causes osmotic diuresis, hyperosmolality, and profound neurologic deficits (coma, seizures)[15][16]. Emergency Treatment Protocol: IV Fluids: First priority. 0.9% NaCl (1 L/hr) to maintain urine output (30–60 mL/hr)[14][15]. Add 5%–10% dextrose when glucose reaches ~250 mg/dL to prevent hypoglycemia and cerebral edema[14][15]. Potassium: Check K⁺ BEFORE starting insulin. Insulin shifts K⁺ intracellularly, causing life-threatening hypokalemia if uncorrected[15]. Continuous IV Regular Insulin: 0.1 U/kg/hr; target glucose reduction of 36–54 mg/dL/hr[15]. 4. Hypoglycemia & Chronic Complications Hypoglycemia (<70 mg/dL): Treat via Rule of 15 (15–20g fast-acting carbs, recheck in 15 min)[16][17]. Unconscious: 20–50 mL 50% Dextrose IV or 1 mg Glucagon IM/SQ (turn on side to prevent aspiration)[17]. Chronic Complications: Driven by angiopathy[18]. Macrovascular (CVD, stroke, PAD) managed via BP (<140/90) and lipid control[19]. Microvascular annual screening: Retinopathy (dilated eye exam), Nephropathy (urine albumin/creatinine; treat with ACEi/ARBs), and Neuropathy (monofilament test, daily foot inspection)[20].

• Transcript

VS ACLS | Lidocaine v Amiodarone

80/20 Comparative Summary: Amiodarone vs. Lidocaine 1. Class & Mechanism of Action Amiodarone (Cordarone): Class III antiarrhythmic with Class I, II, III, and IV actions[1][2]. Primarily blocks potassium channels in phases 2 and 3, delaying repolarization and prolonging effective refractory period[1]. Weakly blocks sodium channels (phase 0 upstroke), depresses SA/AV automaticity, blocks calcium channels, noncompetitively inhibits alpha/beta receptors, and causes vasodilation[2][3]. Lidocaine: Class IB antiarrhythmic and amide local anesthetic[4]. Selectively inhibits fast sodium channel influx in phase 0, shortening action potential duration and refractory period in His-Purkinje tissue while suppressing automaticity/reentry preferentially in ischemic myocardium[6]. Blocks nerve sodium channels for local anesthesia[7]. 2. Indications & ACLS Role Amiodarone: Indicated for life-threatening recurrent ventricular fibrillation (VF), hemodynamically unstable ventricular tachycardia (VT), and atrial fibrillation[8]. Used in ACLS CPR for VF/pVT unresponsive to defibrillation[11][12]. Lidocaine: Indicated IV for acute life-threatening VF/VT (post-MI/cardiac surgery) and ACLS CPR[5][13]. Used topically/regionally for local anesthesia[4][14]. In pediatric ACLS, associated with higher return of spontaneous circulation (ROSC) rates than amiodarone[15][16]. 3. Pharmacokinetics & Administration Amiodarone: Oral, IV, or IO route[17]. Lipophilic (Vd ~70 L/kg), delayed steady state (1–5 months), and long terminal half-life (mean 53 days)[19][20]. Hepatically metabolized via CYP3A4/2C8 to active metabolite DEA[21]. Dilute in D5W only, use volumetric pumps and in-line filters, and avoid PVC containers/tubing for long infusions due to drug adsorption and DEHP leaching[22]. Lidocaine: Administered IV, IO, IM, topically, or transdermally[4]. Rapid IV onset (immediate) with short duration (10–20 min)[27]. Hepatically metabolized via CYP1A2/3A4 to MEGX and GX; >98% excreted renally[28][29]. Given as IV bolus load followed by continuous infusion[13][30]. 4. Adverse Effects & Safety Warnings Amiodarone: Boxed warnings for pulmonary toxicity (up to 17%), fatal hepatotoxicity, and proarrhythmia (QT prolongation, Torsades de Pointes)[31]. Contains ~37% iodine, causing thyroid dysfunction[36]. Causes hypotension, phlebitis (>3 mg/mL), corneal deposits, and photosensitivity[32]. Contraindicated in 2nd/3rd degree AV block, SSS, and severe bradycardia[33]. Lidocaine: Toxicity causes CNS effects (seizures, confusion, dysarthria) and cardiovascular collapse (bradycardia, hypotension, arrest)[40]. Boxed warning prohibits viscous lidocaine for infant teething pain[44]. Requires 50% infusion rate reduction after 24 hours or in heart failure/hepatic impairment[30].

• Transcript

ACLS VS | Intro to The Comparison

this is the intro to a new segment comparing two drugs or disease processes to bring you more clarity.

• Transcript